Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00317395 · ClinicalTrials.gov registry record · Phase 2
Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
A Phase 2 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 2
- Development phase
- 3,241
- Enrollment target
NCT00317395: Completed Phase 2 study, sponsored by Sanofi.
NCT00317395 is a Phase 2 study that has completed, run by Sanofi. The registered enrollment target is 3,241 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2337% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00317395, a Phase 2 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3,241 participants
- Enrollment target
Study Summary
Primary objective: To demonstrate the clinical efficacy of otamixaban (dose effect via 5 intravenous \[IV\] regimens) in patients with moderate-to-high-risk non-ST elevation acute coronary syndromes (ACS) and planned early invasive strategy. Secondary objectives: To evaluate safety and assess pharmacokinetics (PK) and pharmacodynamics (PD).
Interventions
- DRUG eptifibatide
- DRUG Otamixaban (XRP0673)
- DRUG unfractionated heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,241 participants |
| Start Date | 2006-06 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
What the finished NCT00317395 record still lists
NCT00317395 is an interventional study that assigns participants to a tested intervention. Its 3,241 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (2337% higher).
The record links to 0 conditions, and to 3 interventions - of which eptifibatide is the first listed.
NCT00317395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00317395 about?
NCT00317395 is a clinical study titled "Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome". Primary objective: To demonstrate the clinical efficacy of otamixaban (dose effect via 5 intravenous \[IV\] regimens) in patients with moderate-to-high-risk non-ST elevation acute coronary syndromes (ACS) and planned early invasive strategy. Secondary objectives: To evaluate safety and assess pharm...
What is the current status of trial NCT00317395?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3,241 participants. The study started on 2006-06. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00317395?
The interventions under investigation include: eptifibatide (DRUG), Otamixaban (XRP0673) (DRUG), unfractionated heparin (DRUG).
Who is sponsoring clinical trial NCT00317395?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00317395's enrollment target sits among peer trials
3,241 6th of 2000 higher than 1,995 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT06587529 · 3,218 participants · NA
Rigorous Evaluation of the READY to Stand Curriculum to Prevent the Commercial Sexual Exploitation of Children
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
- NCT06760507 · 3,209 participants · NA
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia